ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	41/298	191/7206	5.21458229711e-19
ko05340	Primary immunodeficiency	16/298	30/7206	4.24172000265e-15
ko04650	Natural killer cell mediated cytotoxicity	25/298	97/7206	6.59753535883e-14
ko05164	Influenza A	32/298	167/7206	1.49578279013e-13
ko04380	Osteoclast differentiation	28/298	134/7206	5.78133701118e-13
ko05140	Leishmaniasis	20/298	75/7206	1.16383691242e-11
ko05152	Tuberculosis	31/298	187/7206	1.99697234481e-11
ko05330	Allograft rejection	12/298	24/7206	3.48411936547e-11
ko05145	Toxoplasmosis	25/298	126/7206	3.5658479648e-11
ko04612	Antigen processing and presentation	19/298	77/7206	1.69058244191e-10
ko05168	Herpes simplex infection	29/298	182/7206	2.48412464811e-10
ko05332	Graft-versus-host disease	10/298	18/7206	4.11170247256e-10
ko05321	Inflammatory bowel disease (IBD)	16/298	56/7206	4.57008433858e-10
ko05162	Measles	23/298	120/7206	4.64914339376e-10
ko04621	NOD-like receptor signaling pathway	26/298	157/7206	9.38308788338e-10
ko04659	Th17 cell differentiation	21/298	106/7206	1.44761456171e-09
ko04660	T cell receptor signaling pathway	21/298	124/7206	2.74832731781e-08
ko04640	Hematopoietic cell lineage	15/298	64/7206	3.17702603103e-08
ko04620	Toll-like receptor signaling pathway	18/298	100/7206	1.06164974786e-07
ko05150	Staphylococcus aureus infection	11/298	36/7206	1.19944365562e-07
ko05320	Autoimmune thyroid disease	10/298	29/7206	1.25331015368e-07
ko04658	Th1 and Th2 cell differentiation	17/298	96/7206	3.09243787411e-07
ko04064	NF-kappa B signaling pathway	17/298	96/7206	3.09243787411e-07
ko04940	Type I diabetes mellitus	10/298	32/7206	3.61355184282e-07
ko04630	Jak-STAT signaling pathway	20/298	132/7206	3.94789308551e-07
ko04062	Chemokine signaling pathway	25/298	201/7206	6.7784858992e-07
ko04217	Necroptosis	23/298	178/7206	9.81742326362e-07
ko04672	Intestinal immune network for IgA production	10/298	37/7206	1.62261959666e-06
ko05133	Pertussis	15/298	87/7206	2.21309708268e-06
ko04662	B cell receptor signaling pathway	15/298	88/7206	2.56974824264e-06
ko05310	Asthma	7/298	17/7206	2.62368723402e-06
ko04145	Phagosome	21/298	162/7206	2.79952053138e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	23/298	191/7206	3.38273602426e-06
ko05144	Malaria	10/298	45/7206	1.10698480751e-05
ko04664	Fc epsilon RI signaling pathway	13/298	77/7206	1.34731638979e-05
ko04611	Platelet activation	19/298	163/7206	3.8871005188e-05
ko05161	Hepatitis B	19/298	173/7206	8.83397829546e-05
ko04622	RIG-I-like receptor signaling pathway	10/298	62/7206	0.000199960730544
ko05323	Rheumatoid arthritis	12/298	89/7206	0.000273114166648
ko05142	Chagas disease (American trypanosomiasis)	15/298	130/7206	0.000284814998135
ko03050	Proteasome	9/298	54/7206	0.00032279320608
ko04610	Complement and coagulation cascades	11/298	79/7206	0.000368482093393
ko04666	Fc gamma R-mediated phagocytosis	14/298	122/7206	0.000478609467824
ko05160	Hepatitis C	16/298	153/7206	0.000552847258163
ko05034	Alcoholism	1/298	238/7206	0.00074138733433
ko04514	Cell adhesion molecules (CAMs)	14/298	130/7206	0.000909094623541
ko00590	Arachidonic acid metabolism	8/298	52/7206	0.00119736307214
ko05416	Viral myocarditis	8/298	55/7206	0.00174010171326
ko05131	Shigellosis	10/298	82/7206	0.00191819689691
ko05146	Amoebiasis	11/298	99/7206	0.00246953267343
ko04623	Cytosolic DNA-sensing pathway	6/298	41/7206	0.0063030818711
ko05132	Salmonella infection	10/298	98/7206	0.0070325697892
ko04310	Wnt signaling pathway	1/298	181/7206	0.00717113396249
ko05143	African trypanosomiasis	5/298	32/7206	0.00940073713171
ko05224	Breast cancer	1/298	174/7206	0.0105818151025
ko04670	Leukocyte transendothelial migration	13/298	151/7206	0.0110993224028
ko05016	Huntington's disease	2/298	215/7206	0.0131397966828
ko04152	AMPK signaling pathway	1/298	161/7206	0.0150134735345
ko04360	Axon guidance	3/298	233/7206	0.0189188608149
ko04210	Apoptosis	14/298	180/7206	0.0208673383284
ko05012	Parkinson's disease	1/298	155/7206	0.02217094242
ko05166	HTLV-I infection	20/298	292/7206	0.0236030619672
ko04390	Hippo signaling pathway	2/298	188/7206	0.0249313160467
ko04114	Oocyte meiosis	1/298	139/7206	0.0311794286197
ko04080	Neuroactive ligand-receptor interaction	9/298	423/7206	0.0315082113076
ko04668	TNF signaling pathway	10/298	120/7206	0.0324578116009
ko05206	MicroRNAs in cancer	2/298	177/7206	0.034931019484
ko04144	Endocytosis	22/298	342/7206	0.0359449329557
ko04728	Dopaminergic synapse	2/298	185/7206	0.0363251228888
ko00966	Glucosinolate biosynthesis	1/298	1/7206	0.0413544268664
ko04915	Estrogen signaling pathway	1/298	131/7206	0.0448263579612
ko04910	Insulin signaling pathway	2/298	172/7206	0.0495157986794